(Circulation. 2000;102:e27.)
© 2000 American Heart Association, Inc.
Correspondence |
Section of Neurology and Stroke Research Unit, Hospital Universitari Doctor Josep Trueta, Girona, Spain, jserenal@meditex.es
To the Editor:
We read with great interest the article by Agmon et al,1
which was a transesophageal
echocardiographic study comparing the frequency of
atrial septal aneurysm (ASA) in patients with cerebral
ischemic stroke with a large group from the general population.
They found that the odds of ASA were 3.65 times greater (95%
confidence interval, 1.64 to 8.13) in patients than in controls after
adjustment for age and sex. The frequency of patent foramen ovale (PFO)
in patients and controls with ASA was similar (
56%); however, the
frequency of PFO among patients and controls without ASA was not
reported. Given that a large right-to-left shunt due to PFO is
associated both with ASA and an increased risk of ischemic
stroke,2 the authors should have given the odds of ASA
adjusted for the presence of PFO. It is possible that ASA is only an
anatomical defect associated with PFO and does not have a
pathophysiological role of its own. This fact is
important not only from an etiopathogenic point of view but also from a
practical one. A noninvasive diagnostic procedure, such as
transcranial Doppler, which cannot detect ASA but is
highly accurate in the diagnosis of PFO, may be sufficient as a
screening test in stroke patients.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |